Description
Everolimus delays disease progression in patients with advanced lung and gastrointestinal neuroendocrine tumors
Article: Everolimus delays disease progression in patients with advanced lung and gastrointestinal neuroendocrine tumors
€3.03
Related products
-
Article: INTRODUCTION
€3.03 Add to cart -
Article: Highlights in melanoma
€3.03 Add to cart -
Article: Highlights in urologic cancer
€3.03 Add to cart -
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€3.03 Add to cart
Reviews
There are no reviews yet.